Cypress Asset Management Inc Astrazeneca PLC Transaction History

Cypress Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 22, 2021	SELL	$47.16 - $54.44 $200,430 - $231,370	-4,250 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$43.1 - $55.31 $183,175 - $235,067	4,250 New	4,250 $225,000
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $203,589 - $226,190	-6,175 Closed	0 $0
Q4 2017 Jan 31, 2018	SELL	$32.09 - $34.78 $14,440 - $15,651	-450 Reduced 6.79%	6,175 $214,000
Q3 2017 Nov 08, 2017	BUY	$28.96 - $34.0 $191,860 - $225,250	6,625	6,625 $224,000

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Cypress Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cypress Asset Management Inc with notifications on news.